The Nasdaq Stock Market® Welcomes 14 New ETPs in the Second Quarter of 2017
The Nasdaq Stock Market® Welcomes 14 New ETPs in the Second Quarter of 2017
Powered by WPeMatico
This Biotech Finds Its Stride With Kidney Cancer Treatment – Investor’s Business Daily
Investor's Business Daily |
This Biotech Finds Its Stride With Kidney Cancer Treatment
Investor's Business Daily The South San Francisco-based biotech has notched a series of achievements in recent months — posting first-time operating profit, confirming the effectiveness of its breakout compound for treating kidney cancer and retiring nearly all its debt. |
Dova and Novartis-backed Aileron file for new IPOs as biotech … – FierceBiotech
FierceBiotech |
Dova and Novartis-backed Aileron file for new IPOs as biotech ...
FierceBiotech After a poor 2016 and a slow start to 2017, biotech IPOs have started to pick up in recent months and now two upstarts are looking to make their offering. and more » |